Bloom Burton & Co. Announces the 2020 Bloom Burton Award Gala
Annual Award Recognizes the Most Significant Contributor to Canada’s Innovative Healthcare Industry
Original press release here
January 28, 2020 07:30 AM Eastern Standard Time
TORONTO–(BUSINESS WIRE)–Bloom Burton & Co. (“Bloom Burton”) is thrilled to announce the 2020 Bloom Burton Award Gala, to be held at the Four Seasons Hotel in Toronto, Ontario, Canada on Thursday, September 24, 2020. Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year. Nominees will be accepted from any of the biotechnology, pharmaceutical, medical device, diagnostic/imaging, research instrumentation, consumer health, services or healthcare IT sectors, and equal consideration will be given to contributions across any stage of development – from discovery to commercial end markets. The Bloom Burton Award recognizes the individual for their specific, significant contribution from the previous year.
The Bloom Burton Award winner will be chosen by an esteemed panel of judges, all of whom are respected international leaders in healthcare investment, entrepreneurship and journalism:
- Michael Altman, Managing Director, Perceptive Advisors
- Christopher Arendt, Head of Oncology Therapeutic Area Unit, Takeda
- Karen Bernstein, Co-Founder and Chairman, BioCentury Inc.
- Carl Gordon, Partner and Co-Head of Global Private Equity, OrbiMed Advisors
- Dennis Purcell, Founder and Senior Advisor, Aisling Capital
- Melinda Richter, Global Head of Johnson & Johnson Innovation – JLABS
- Camille Samuels, Partner, Venrock
Nominations may be submitted by the public at large on or before April 6, 2020. A narrowed list of three finalists will be announced at the Bloom Burton & Co. Healthcare Investor Conference, April 20 to April 21, 2020. All three finalists, along with their family and friends, will be invited to and celebrated at the Bloom Burton Award Gala on September 24, 2020. Each of the three finalists will receive a $25,000 cash prize, and a single winner will receive the 2020 Bloom Burton Award. A limited number of tickets are available for industry sponsors and individuals; please visit www.bloomburton.com for more information.
Jolyon Burton, President of Bloom Burton & Co. commented, “When we see the triumphs of Canadians, who have brought about tangible, world-class healthcare innovations for society’s benefit, we feel grateful that the Bloom Burton Award exists. The Bloom Burton Award shines a bright light on these courageous healthcare innovators for their amazing work, but also lets others know their journey that is often fraught with very significant obstacles. We cherish their spirit and desire to make meaningful, positive impact and look forward to celebrating the next three finalists this coming September.”
Kindly send single page nomination letters to:
Tel: (416) 640-7573
For table sponsorship and other inquiries:
Chairman & CEO
Tel: (416) 640-7580
About Bloom Burton & Co.
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical, legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton Securities Inc. is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF). Please visit www.bloomburton.com to learn more.